Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
A new Bayesian meta-analysis finds that left atrial appendage occlusion (LAAO) is associated with a higher rate of ischemic stroke compared to oral anticoagulation in atrial fibrillation patients. But there's a silver lining: LAAO was also tied to a 45% lower rate of hemorrhagic stroke. Experts say the tradeoff calls for individualized, shared decision-making rather than a one-size-fits-all approach.
A new Bayesian meta-analysis of six randomized trials — covering 7,004 atrial fibrillation (AF) patients — finds that left atrial appendage occlusion (LAAO) is associated with a higher rate of ischemic stroke compared to oral anticoagulation (OAC), but the picture is more nuanced than that headline suggests. The elevated ischemic stroke risk came with 94% confidence, yet the overall stroke difference was smaller, largely because LAAO was linked to a 45% lower rate of hemorrhagic stroke.
The authors caution that the absolute excess risk is small and statistically weak, and that the hemorrhagic stroke benefit may meaningfully offset the ischemic risk — especially for patients who are already at high bleeding risk on anticoagulants. Experts note the findings are "hypothesis-generating" and support continued development of LAAO as a viable alternative to long-term anticoagulation.
Key Takeaways:
Why it matters: For clinicians managing AF patients — particularly those with high bleeding risk — this meta-analysis reinforces that LAAO and OAC offer broadly equivalent stroke and bleeding protection overall, but the right choice depends heavily on individual patient factors, values, and anatomy. A decision-support algorithm is still needed.
